Ip Group Executive Interview Edison Group In this interview, ip group’s ceo, greg smith, highlights the potentially transformational implications of pfizer’s acquisition of metsera (for up to $7.3bn, of which $4.9bn is in upfront. Ip group ceo greg smith discusses why he believes the uk has the potential to become a science superpower and the role ip group and the wider investment community needs to play to make this happen.
Ip Leadership In this interview, ip group's ceo, greg smith, highlights the potentially transformational implications of pfizer's acquisition of. Greg smith executive interview with edison october 2025. Edison's dan ridsdale recently caught up with the company's ceo, greg smith, discussing the group’s performance and portfolio over the course of h1, the government’s ambition for the uk to become. In this interview, ip group’s ceo, greg smith, discusses the company's performance and outlook. he explores the factors behind its fivefold year on year increase in realisations to £180m in.
Ip Group Executive Interview Edison Group Edison's dan ridsdale recently caught up with the company's ceo, greg smith, discussing the group’s performance and portfolio over the course of h1, the government’s ambition for the uk to become. In this interview, ip group’s ceo, greg smith, discusses the company's performance and outlook. he explores the factors behind its fivefold year on year increase in realisations to £180m in. In this interview, ip group’s ceo, greg smith, highlights the potentially transformational implications of pfizer’s acquisition of metsera (for up to $7.3bn, of which $4.9bn is in upfront cash), whose met 097 anti obesity drug is progressing through phase ii. In this interview, ip group's ceo, greg smith, discusses the company's performance and outlook. he explores the factors behind. In this interview, greg smith, ceo of ip group, discusses the company’s recent achievements, including nav stabilisation and successful exits that have strengthened the group’s position. In this interview, ip group ceo greg smith introduces the company and explains what differentiates its investment model and approach. he talks about the group’s international positioning and parkwalk, the group’s uk fund management business.
Ip Group Executive Interview Edison Group In this interview, ip group’s ceo, greg smith, highlights the potentially transformational implications of pfizer’s acquisition of metsera (for up to $7.3bn, of which $4.9bn is in upfront cash), whose met 097 anti obesity drug is progressing through phase ii. In this interview, ip group's ceo, greg smith, discusses the company's performance and outlook. he explores the factors behind. In this interview, greg smith, ceo of ip group, discusses the company’s recent achievements, including nav stabilisation and successful exits that have strengthened the group’s position. In this interview, ip group ceo greg smith introduces the company and explains what differentiates its investment model and approach. he talks about the group’s international positioning and parkwalk, the group’s uk fund management business.
Comments are closed.